Thomas D. Chittenden
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Molecular Biology top 5%
- Cell death mechanisms and regulation
- Ubiquitin and proteasome pathways
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 8
- Cancer-related Molecular Pathways 4
- CAR-T cell therapy research 2
- Cytokine Signaling Pathways and Interactions 2
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Susan H. Erster (1 shared paper)Alexander I. Zaika (1 shared paper)Ute Martha Moll (1 shared paper)Petr Pančoška (1 shared paper)Oleksi Petrenko (1 shared paper)Motohiro Mihara (1 shared paper)Victor S. Goldmacher (10 shared papers)James A. DeCaprio (3 shared papers)
- Journals
- Blood (5 papers)Molecular Cancer Therapeutics (3 papers)Cell (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer Cell (1 paper)
- Partner nations
- United StatesFranceJapan
In The Last Decade
Thomas D. Chittenden
21 papers receiving 4.9k citations
Thomas D. Chittenden's Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 2.4k
- Molecular Biology 2.6k
- Immunology 664
- Hematology 344
- Parasitology 199
Countries citing papers authored by Thomas D. Chittenden
This map shows the geographic impact of Thomas D. Chittenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Chittenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Chittenden more than expected).
Fields of papers citing papers by Thomas D. Chittenden
This network shows the impact of papers produced by Thomas D. Chittenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Chittenden. The network helps show where Thomas D. Chittenden may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas D. Chittenden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53 Has a Direct Apoptogenic Role at the Mitochondria Hit paper breakdown → | 2003 | 1485 |
| 2 | Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties Hit paper breakdown → | 1992 | 765 |
| 3 | 1992 | 519 | |
| 4 | 2006 | 403 | |
| 5 | 1999 | 380 | |
| 6 | 2001 | 375 | |
| 7 | 2014 | 289 | |
| 8 | An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. | 2003 | 273 |
| 9 | 2015 | 199 | |
| 10 | 2018 | 150 | |
| 11 | 2013 | 79 | |
| 12 | 2002 | 62 | |
| 13 | 1993 | 39 | |
| 14 | 2022 | 20 | |
| 15 | 2016 | 16 | |
| 16 | 2024 | 11 | |
| 17 | 2012 | 7 | |
| 18 | 2012 | 7 | |
| 19 | 2016 | 6 | |
| 20 | 2008 | 4 |
About Thomas D. Chittenden
Thomas D. Chittenden is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Physiology and Parasitology, having authored 21 papers that have together received 5.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (8 papers), Cancer-related Molecular Pathways (4 papers), Cell death mechanisms and regulation (3 papers), CAR-T cell therapy research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cytomegalovirus and herpesvirus research (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (2.4k citations), Molecular Biology (2.6k citations), Immunology (664 citations), Hematology (344 citations) and Parasitology (199 citations). Thomas D. Chittenden has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Susan H. Erster, Alexander I. Zaika, Ute Martha Moll, Petr Pančoška, Oleksi Petrenko, Motohiro Mihara, Victor S. Goldmacher, James A. DeCaprio, Laura M. Bartle and Anna Skaletskaya. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Cell, Proceedings of the National Academy of Sciences and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.